USANA Health Sciences (USNA)
(Delayed Data from NYSE)
$46.71 USD
-1.11 (-2.32%)
Updated May 24, 2024 04:00 PM ET
After-Market: $46.65 -0.06 (-0.13%) 7:58 PM ET
2-Buy of 5 2
A Value C Growth C Momentum A VGM
Price, Consensus and EPS Surprise
USNA 46.71 -1.11(-2.32%)
Will USNA be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for USNA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for USNA
USNA vs. STVN: Which Stock Should Value Investors Buy Now?
USNA or STVN: Which Is the Better Value Stock Right Now?
USNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
USANA Health Sciences (USNA) Q1 Earnings and Revenues Top Estimates
Indivior (INDV) Surges 5.6%: Is This an Indication of Further Gains?
USANA Health Sciences (USNA) Q4 Earnings and Revenues Beat Estimates
Other News for USNA
USANA Celavive Postbiotic Barrier Balm Named to Best in Skincare List
Insider Sale: Chief People Officer Paul Jones Sells Shares of Usana Health Sciences Inc (USNA)
KXI: Consumer Staples Dashboard For May
USANA HR Executive Awarded for Excellence in his Field
Analyst Favorites With Strong Buyback Activity: USANA Health Sciences Ranks As a Top Pick